|
HNRNPC expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.181400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.865890E-02 |
| Normal-vs-Stage2 |
1.720310E-02 |
| Normal-vs-Stage3 |
1.617500E-04 |
| Normal-vs-Stage4 |
3.955600E-03 |
| Stage1-vs-Stage2 |
4.113400E-01 |
| Stage1-vs-Stage3 |
7.041400E-03 |
| Stage1-vs-Stage4 |
2.247200E-01 |
| Stage2-vs-Stage3 |
2.940800E-01 |
| Stage2-vs-Stage4 |
8.612000E-01 |
| Stage3-vs-Stage4 |
3.256800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.159500E-03 |
| Normal-vs-AfricanAmerican |
1.475550E-02 |
| Normal-vs-Asian |
6.100400E-01 |
| Caucasian-vs-AfricanAmerican |
9.140000E-01 |
| Caucasian-vs-Asian |
4.752600E-01 |
| AfricanAmerican-vs-Asian |
4.788400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.770200E-04 |
| Normal-vs-Female |
3.519700E-02 |
| Male-vs-Female |
1.863800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.261900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.243560E-03 |
| Normal-vs-Age(61-80Yrs) |
4.900100E-03 |
| Normal-vs-Age(81-100Yrs) |
5.543000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.491000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.539000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.851000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.037800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.479350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.049700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.144200E-01 |
| Normal-vs-Grade 2 |
8.461800E-02 |
| Normal-vs-Grade 3 |
7.54820000000711E-05 |
| Normal-vs-Grade 4 |
9.174400E-04 |
| Grade 1-vs-Grade 2 |
8.372000E-02 |
| Grade 1-vs-Grade 3 |
8.831600E-04 |
| Grade 1-vs-Grade 4 |
9.624400E-03 |
| Grade 2-vs-Grade 3 |
2.0379999999931E-05 |
| Grade 2-vs-Grade 4 |
4.295300E-03 |
| Grade 3-vs-Grade 4 |
9.749400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.259000E-01 |
| Normal-vs-ccB subtype |
1.01190000045825E-07 |
| ccA subtype-vs-ccB subtype |
5.30131494258512E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.800100E-03 |
| Normal-vs-N1 |
2.157500E-02 |
| N0-vs-N1 |
2.822800E-01 |
|
|
